Rituximab for steroid-refractory chronic graft-versus-host disease

Prevention of Epstein-Barr virus–lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

2002 • 400 citations

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

2004 • 399 citations

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients

2000 • 384 citations

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

2001 • 373 citations

CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation

2000 • 285 citations

Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

2002 • 280 citations

Chronic graft-versus-host disease: clinical manifestation and therapy

2001 • 266 citations

How I treat chronic graft-versus-host disease

2001 • 252 citations

Development and validation of a scale to measure symptoms of chronic graft-versus-host disease

2002 • 230 citations

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

2003 • 203 citations

A humanized non–FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

2002 • 173 citations

Minor Histocompatibility Antigen DBY Elicits a Coordinated B and T Cell Response after Allogeneic Stem Cell Transplantation

2004 • 171 citations

Chronic graft versus host disease

2004 • 163 citations

Quality of life following bone marrow transplantation: a comparison of patient reports with population norms

1997 • 161 citations

Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors

2003 • 156 citations

Anti-CD20 Chimeric Monoclonal Antibody Treatment of Refractory Immune-Mediated Thrombocytopenia in a Patient with Chronic Graft-versus-Host Disease

2000 • 143 citations

Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease

2004 • 135 citations

Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease

2001 • 134 citations

Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival

2004 • 132 citations

Thalidomide for treatment of patients with chronic graft-versus-host disease

2000 • 130 citations

The therapeutic potential of anti-CD20

2005 • 124 citations

Scoring system for monitoring oral lichenoid lesions: A preliminary study

2005 • 119 citations

B cells as therapeutic targets for rheumatic diseases

2004 • 117 citations

Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation

2005 • 98 citations

A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma

2000 • 95 citations

Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high‐risk aggressive non‐Hodgkin's lymphoma

2003 • 76 citations

Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial

2001 • 74 citations

Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation

1998 • 61 citations

Pre-emptive therapy with rituximab for prevention of Epstein–Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation

2003 • 52 citations

The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantation

1996 • 47 citations

Use of rituximab and irradiated donor-derived lymphocytes to control Epstein–Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation

1999 • 45 citations

One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.

2003 • 29 citations

Cyclosporin A and chronic graft versus host disease.

1990 • 24 citations

Petreatment with Rituximab Reduces the Incidence of Chronic Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation in Patients with B Cell Lymphoma.

2004 • 4 citations

Rituxan for steroid-refractory chronic GVHD

2005 • 3 citations

Rituximab Therapy for Steroid-Refractory Chronic GVHD: Safety and Efficacy Analysis.

2004 • 2 citations

Cited By (0)

No citing papers found in database